[HTML][HTML] Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis …
SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - RSC …, 2023 - pubs.rsc.org
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
[PDF][PDF] Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis …
SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - 2023 - researchgate.net
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological …
SM Al-Muntaser, AA Al-Karmalawy… - RSC …, 2023 - pubmed.ncbi.nlm.nih.gov
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
[HTML][HTML] Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis …
SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - RSC …, 2023 - ncbi.nlm.nih.gov
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological …
SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - RSC …, 2023 - europepmc.org
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
[PDF][PDF] Novel 4-Thiophenyl-Pyrazole, Pyridine, and Pyrimidine Derivatives as Potential Antitumor Candidates Targeting Both EGFR and VEGFR-2; Design, Synthesis …
SM Al-Muntasera, AA Al-Karmalawyb, AM El-Naggara… - pdfs.semanticscholar.org
IR spectral data of the target compounds (1b-20a) S7 Figure S3. IR spectrum of compound
1b S7 Figure S4. IR spectrum of compound 2a S7 Figure S5. IR spectrum of compound 2b …
1b S7 Figure S4. IR spectrum of compound 2a S7 Figure S5. IR spectrum of compound 2b …
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological …
SM Al-Muntaser, AA Al-Karmalawy… - RSC …, 2023 - ui.adsabs.harvard.edu
Abstract Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential dual
EGFR/VEGFR-2 inhibitors with promising antimicrobial activity as well. In this article, we …
EGFR/VEGFR-2 inhibitors with promising antimicrobial activity as well. In this article, we …
[PDF][PDF] Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis …
SM Al-Muntaser, AA Al-Karmalawy, AM El-Naggar… - 2023 - researchgate.net
In this article, we continued our previous effort to develop new selective anticancer
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …
candidates based on the basic pharmacophoric requirements of both EGFR and VEGFR-2 …